UK TRADING UPDATE SUMMARY: Pawnbroker H&T Declares Interest Holiday
UK TRADING UPDATE SUMMARY: Pawnbroker H&T Declares Interest Holiday
Read moreUK TRADING UPDATE SUMMARY: Pawnbroker H&T Declares Interest Holiday
Read moreUK TRADING UPDATE SUMMARY: Kier To Reduce Salary For 6,500 Employees
Read more(Sharecast News) - Ergomed said it would provide drug safety services for a US trial to assess the benefits of a rheumatoid arthritis treatment for patients suffering from severe coronavirus infections.
Read more(Sharecast News) - Pharmaceutical services company Ergomed reported a 26.1% improvement in its revenue to ?68.3m on a comparable basis in its full-year results on Wednesday.
Read moreErgomed Swings To Profit And Revenue Jumps In "Transformational" 2019
Read moreErgomed To Provide Clinical Research For Covid-19 Treatment Study
Read more(Sharecast News) - Specialist pharmaceutical services company Ergomed announced on Wednesday the start of a study of 'siltuximab', an interleukin-6 targeted monoclonal antibody, for the treatment of patients with Covid-19 who had developed serious respiratory complications.
Read moreDIRECTOR DEALINGS: Four Ergomed Directors Buy GBP187,000 In Shares
Read more(Sharecast News) - Pharmaceutical industry services provider Ergomed said on Wednesday that it had continued to deliver strong year-on-year top-line growth and now expects full-year underlying earnings to come in ahead of current market expectations.
Read moreErgomed Says 2019 Revenue To Climb Amid Growth Across The Board
Read more(Sharecast News) - Pharmaceutical services provider Ergomed announced the acquisition of Ashfield Pharmacovigilance, a specialist pharmacovigilance services provider based in Cary in the 'Research Triangle' of North Carolina on Monday.
Read moreErgomed Buys Ashfield Pharmacovigilance From UDG For USD10 Million
Read moreOryx International Growth Fund In First-Half Net Asset Value Rise
Read moreCircassia Pharmaceuticals CEO Retires; Reiterates 2019 Guidance
Read moreErgomed Appoints Former Covance Director As Chief Operating Officer
Read more